Targeting ALS with Synergistic Combinations of Therapies

RARECast - A podcast by RARECast - Thursdays

Categories:

Business

Alon Ben-Noon, CEO of NeuroSense Therapeutic’s, discusses the company's approach to developing therapies using synergistic combinations of existing drugs, its current lead therapeutic candidate, and its efforts to target other neurodegenerative conditions beyond ALS.